Allergic rhinitis (AR) is characterized by Th2 polarized immune response. Consequently, allergic patients have a defect in IFN-yproduction. So far, however, all the experimental studies have investigated only the IFN-y production induced by the causal allergen. The aim of this study is to investigate whether there is a difference in the in vitro IFN-y production, using different allergens as stimuli, in patients presenting with rhinitis due to pollen allergy. Forty-one AR patients with pollen allergy were enrolled. IFN-y-specific producing cells were stimulated with PHA, causal pollen, and House Dust Mite (HDM). IFN-y production was assessed by cytokine ELISPOT. IFN-y production of peripheral blood mononuclear cells (PBMC) stimulated by specific pollen was significantly lower than IFN-y production of PBMC stimulated by HDM (p<O.OOl). IFN-y production of PBMC stimulated by specific pollen was significantly lower than IFN-y production of PBMC stimulated by PHA (p<O.OOl). Moreover, in the HDM-sensitized patients, there seems to be a trend for a different defect. The present study highlights that the defective IFN-y production is allergen specific and that HDM sensitization may also affects this parameter.
Allergic rhinitis (AR) is sustained by a mucosal inflammation, characterized by mast cell and eosinophil activation. This inflammatory reaction is orchestrated by T helper (Th) cells. Th cells are subdivided into two main subpopulations, on the basis of their in vitro cytokine production profile. Thl cells primarily produce interferon (lFN)-y and IL-2, whereas Th2 subset preferentially produces IL-4, IL-5, and IL-13 (1) .
Th2 cells play an important role in the pathogenesis of AR, as IL-4 promotes isotype switching to IgE synthesis, while IL-5 promotes, mostly in the nasal mucosa, eosinophil accumulation and activation (2) (3) . Indeed, Th2 derived cytokines have been demonstrated in biopsies of the nasal mucosa of patients with AR (2) . In addition, peripheral blood mononuclear cells (PBMC) display a predominant interleukin (lL)-4 production by Th2 cells over IFN-y expression by Thl, which constitutes the so-called "Th2 polarization" (4). This Th2 polarization is typically characterized by a reduced IFN-y production. Moreover, the therapeutic administration of the causal allergen, such as the specific immunotherapy, induces hyposensitization by modifying peripheral and mucosal predominant Th2-responses into a prevalent Th l-polarized response, as evidenced by an increased production of IFN-y (5) (6) (7) (8) . This issue reinforces the concept concerning functional dichotomy between Th l and Th2 response.
So far, however, all experimental studies have always investigated the IFN-y production induced by the specific causal allergen only, in in vitro models. Therefore, the aim of the present study is to evaluate whether there is a difference in the in vitro IFN-y production using different allergens as stimuli, in patients presenting with rhinitis due to pollen allergy.
MATERIALS ANO METHODS

Patients
Forty-one patients (17 males and 24 females) with AR due to pollen allergy, were included in the study; 17 ofthem were allergic to Betula alba, 16 to Parietariajudaica and 7 to Graminacee. Moreover, 18 of them were sensitized, but not allergic, also to House Dust Mites (HDM). Their mean age was 39.24 years (SD: 13.8). In order to be enrolled in the study, patients were required to have persistent allergic rhinitis (PER) due to pollen allergy. Patients either with acute upper respiratory infections, or undergoing specific immunotherapy, or using nasal or oral corticosteroids, antileukotrienes and antihistamines within the previous 4 weeks were excluded. Patients with documented allergy to non-pollen allergens were also excluded.
According to validated criteria, in order to make a diagnosis of AR, a history of nasal symptoms and positive results to skin prick test were considered sufficient (9) .
The study was conducted with the approval of the local Ethics Committee and performed with the written informed consent of all participants.
Enumeration ofIFN-y-specific producing cells by cytokine ELiSPOT
PBMC were isolated from heparinized blood samples by Ficoll-Hypaque (Lymphoflot, Biotest, Germany) density gradient centrifugation. The PBMC were washed with PBS and re-suspended in complete medium (RPMI-1640 with 2mmol/l L-glutamine, Invitrogen) with 10% autologous plasma at 2x IQI'6/ml. ELISPOT was performed according to the manufacturer's instructions. In brief, polyvinylidene difluoride plates (Diaclone, France) were coated overnight with IFN-y capture mAb. After saturation with RPMI-IO% fetal calf serum (FCS, Invitrogen), 100 III of PBMC suspension was added per well. The cells were stimulated with phytoemagglutinine (PHA; I ug/rnl; Sigma Aldrich, Italy) as positive control, with allergen extracts used for SLIT for 20 hrs at 37°C and 5% CO 2 in humidified air. The allergen concentration of the whole extract of birch, Parietaria, and grasses, or House Dust Mite (Dermatophagoides farinae), (Anallergo, Florence, Italy) in the final volume of culture medium were respectively 2.5, I, I, and 2 mcg/ml, based on assessment in preliminary experiments. After incubation, the plates were washed with PBS-I % bovine serum albumin (BSA) and incubated with biotinylated detection antibody for I h and 30 min at room temperature (RT). After the washing, streptavidin-Alkaline phosphatase conjugate was added for I h at RT. Finally, BCIPINBT was distributed in wells. Elispot assays were set in duplicates, and detection of spots representing cytokine-producing cells was performed by bioreader (BIO-SYS, Germany).
Statistical analysis
Comparisons between median number of spots for the different stimuli were carried out using a Wilcoxon test for paired data. Patients sensitized to HDM and non-HDM sensitized were compared using the Mann Whitney U test.
RESULTS
Assessment of IFN-y-specijic producing cells by cytokine ELISPOT
In Fig. I , the median number of spots is reported for all the employed stimuli: it is 4.0 for the medium control, 135.0 for PHA, 74.0 for House Oust Mite, and 7.0 for pollens. There is a significant difference between HOM-induced and pollen-induced IFN-y production (p<O.OOI) as well as between PHAinduced and pollen-induced IFN-y production (p<O.OO I). Moreover, there is a significant difference between PHA-induced and HOM-induced IFNy production (p<O.OOI). 18 patients were also sensitized to HOM, though without showing any allergy to HOM (i.e. absence of symptoms after HOM nasal challenge test with the highest concentration of the allergen, such as that used for skin prick test). Therefore, we evaluated the HOMinduced IFN-y production in two subgroups: patients sensitized to HOM and non-HOM-sensitized. Fig. 2 shows that HOM-sensitized patients, stimulated by HOM allergen, produce less IFN-y (median 62.0) than non-HOM-sensitized patients (median 102.0) (p=0.08). Moreover, the production P<O.001 inflammation with typic al eosinophil infiltrate ( 10) . Indeed, there is functional dichotomy between Th I and Th2 cells ( 11) . Th is issue has been reinforced by the evidence that spe cific immunotherapy increases IFN-y production and reduces Th2-dependent cytokines (6) (7) (8) .
Moreover, the phenomenon of polysensitizat ion, such as the production of specific IgE tow ard two or more allergens, is very frequent in allergic patients from earl y childhood (12) . However, it has to be highlighted that sensitization is not synonymous of all ergy, as subj ect s who are simply sen sitized do not pre sent symptoms after allergen exposure, while allergic patients show symptoms after allergen exposure.
Thi s study aims at evaluating the production of IFN -y induced by different stimuli in a group of pati ents with PER due to pollen allergy. PBMC we re stimulated by two different allergens: the cau sal allergen, such as a pollen extract, and an ubiquitous allergen, such as House Dust Mite, which was not the cau sal allergen in such pati ents . The purpose of our study derived from the acknowledgement that, in all preceding studies, only the causal allergen was used in order to stimu late and evaluate cytokine production.
Thu s, the primary goal of the present study is to evaluate whether there is a different IFN-y production using two different allergenic stimuli, i.e. poll en and HOM.
As expected, IFN-y production induced by the causal allergen, such as the pollen, was significantly defective in comparison to that induced by PHA. This finding confirms the paradigm of the Th2 polarization in allergic patients, as the defect ofIFNy production is typicall y allergen-specific. Indeed, usin g another allergen that is not causal, the defect is significantly lower in comparison with the poll eninduced production. Th erefore, this issue provides evidence that the IFN -y de fect is restricted to clones ofT cell s that are specific for the causal allergen .
A pos sible explanation of this successful finding is based on the fact that the ELlSPOT assay is the exvivo assay with the lowest limit of dete ction ofIFN-y producing T cell s, allow ing the reliable detection of as few as 10 specific T cells per I million PBMC (13) (14) .
An other interestin g outcome of the study is that the presence of sensitization may induce a trend of more reduced IFN-y production when using the specific allergenic stimulus. Even though we have not obtained statistically significant values, a trend appears to exist. Our lack of statistical proof may depend on the relatively small cohort of patients. Moreover, these findings are relevant, as allergic rhinitis is a very common disorder (15) and nasal inflammation, that is the most relevant event, depends on Th cells (16) .
However, this study has some limitations: the lack of controls, of data on cytokine profile and cell phenotype. This study was aimed at evaluating the IFN-y production induced by allergenic stimuli, therefore the design did not consider the inclusion of normal subjects as it was considered that normal subjects have scarce response to allergens. Cytokines were not assessed as it is well known that allergic patients clearly show a Th2 polarization. Finally, the ELISPOT assay evaluates only the frequency of cells producing a certain molecule and does not allow to evaluate other issues.
In conclusion, the present study shows that defective IFN-y production in allergic subjects is allergen specific and that the presence of another sensitization may affect this parameter. These preliminary findings need to be confirmed by further studies.
